pre-treatment ctdna linked to increased risk of early recurrence in io-treated melanoma
Published 1 year ago • 119 plays • Length 2:01Download video MP4
Download video MP3
Similar videos
-
0:36
challenges associated with implementing ctdna approaches in melanoma
-
0:42
ctdna in clinical practice for melanoma
-
1:36
ctdna assay for detection of recurrent disease in patients with early-stage breast cancer
-
1:15
the potential applications of ctdna in melanoma
-
0:58
real-world monitoring of circulating tumor dna to predict cancer recurrence
-
1:27
pre-treatment ctdna levels significantly predicts os and pfs in nadim ii
-
6:55
the prognostic value of ctdna in nsclc treated with neoadjuvant chemoimmunotherapy
-
1:26
potential role of ctdna for early-stage breast cancer
-
1:20
can ctdna guide the treatment decision making process in melanoma?
-
2:43
tumor characteristics of patients with recurrence after neoadjuvant ipi nivo in melanoma
-
3:32
the role of ctdna in lung cancer screening
-
0:43
the role of ngs and ctdna in advancing personalized medicine in oncology
-
20:34
role of circulating tumor cells/dna & liquid biopsy in melanoma - david polsky
-
6:41
what are the main treatment options for melanoma?
-
25:44
the latest treatments for melanoma - an overview
-
0:41
will ctdna replace pathologic complete response in nsclc?
-
1:23
role of ctdna in mrd
-
1:51
systemic effects of local administration of anti-ctla4 in early-stage melanoma
-
0:45
the emerging role of ctdna in cancer diagnostics